» Articles » PMID: 38792892

Epigenetic and Coping Mechanisms of Stress in Affective Disorders: A Scoping Review

Overview
Publisher MDPI
Specialty General Medicine
Date 2024 May 25
PMID 38792892
Authors
Affiliations
Soon will be listed here.
Abstract

This review aims to explore the intricate relationship among epigenetic mechanisms, stress, and affective disorders, focusing on how early life experiences and coping mechanisms contribute to susceptibility to mood disorders. Epigenetic factors play a crucial role in regulating gene expression without altering the DNA (deoxyribonucleic acid) sequence, and recent research has revealed associations between epigenetic changes and maladaptive responses to stress or psychiatric disorders. A scoping review of 33 studies employing the PRISMA-S (Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Statement) guidelines investigates the role of stress-induced epigenetic mechanisms and coping strategies in affective disorder occurrence, development, and progression. The analysis encompasses various stress factors, including childhood trauma, work-related stress, and dietary deficiencies, alongside epigenetic changes, such as DNA methylation and altered gene expression. Findings indicate that specific stress-related genes frequently exhibit epigenetic changes associated with affective disorders. Moreover, the review examines coping mechanisms in patients with bipolar disorder and major depressive disorder, revealing mixed associations between coping strategies and symptom severity. While active coping is correlated with better outcomes, emotion-focused coping may exacerbate depressive or manic episodes. Overall, this review underscores the complex interplay among genetic predisposition, environmental stressors, coping mechanisms, and affective disorders. Understanding these interactions is essential for developing targeted interventions and personalized treatment strategies for individuals with mood disorders. However, further research is needed to elucidate specific genomic loci involved in affective disorders and the clinical implications of coping strategies in therapeutic settings.

Citing Articles

Epigenetic Biomarkers in Thrombophilia-Related Pregnancy Complications: Mechanisms, Diagnostic Potential, and Therapeutic Implications: A Narrative Review.

Bardan C, Ionita I, Iordache M, Calamar-Popovici D, Todorescu V, Popescu R Int J Mol Sci. 2025; 25(24.

PMID: 39769397 PMC: 11728153. DOI: 10.3390/ijms252413634.


Predictive power of epigenetic age - opportunities and cautions.

Nardini C, Di Lena P Epigenomics. 2024; 17(2):75-77.

PMID: 39580637 PMC: 11792792. DOI: 10.1080/17501911.2024.2433409.

References
1.
Sun H, Kennedy P, Nestler E . Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology. 2012; 38(1):124-37. PMC: 3521990. DOI: 10.1038/npp.2012.73. View

2.
Hesam-Shariati S, Overs B, Roberts G, Toma C, Watkeys O, Green M . Epigenetic signatures relating to disease-associated genotypic burden in familial risk of bipolar disorder. Transl Psychiatry. 2022; 12(1):310. PMC: 9349272. DOI: 10.1038/s41398-022-02079-6. View

3.
Davis M, Holmes S, Pietrzak R, Esterlis I . Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies. Chronic Stress (Thousand Oaks). 2018; 1. PMC: 5976254. DOI: 10.1177/2470547017710916. View

4.
Kang H, Kim J, Stewart R, Kim S, Bae K, Kim S . Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 44:23-8. DOI: 10.1016/j.pnpbp.2013.01.006. View

5.
Sanwald S, Widenhorn-Muller K, Schonfeldt-Lecuona C, Montag C, Kiefer M . Factors related to age at depression onset: the role of SLC6A4 methylation, sex, exposure to stressful life events and personality in a sample of inpatients suffering from major depression. BMC Psychiatry. 2021; 21(1):167. PMC: 7995700. DOI: 10.1186/s12888-021-03166-6. View